Core Labs Jumps 79% in 6 Months: Time to Buy or Stay on the Sidelines?

CLB shows strong international demand, free cash flow generation and a solid financial position, but near-term U.S. land activity challenges and margin pressure could limit growth.

Zacks Investment Research • Feb 18, 2026

Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y

CLB expects revenues to range from $124 million to $130 million and earnings per share to be between 11 cents and 15 cents for the first quarter of 2026.

Zacks Investment Research • Feb 6, 2026

Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript

Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 5, 2026

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

HOUSTON, Feb. 4, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported fourth quarter 2025 revenue of $138,300,000. Core's operating income was $15,800,000, with earnings per diluted share ("EPS") of $0.15, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $15,700,000, yielding operating margins of over 11% and EPS, ex-items, of $0.21. For the full year 2025, revenue of $526,500,000 was up slightly compared to 2024, generating operating income on a GAAP basis of $56,500,000 and operating income, ex-items, of $58,700,000. The Company's full year EPS, ex-items, was $0.75. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

PRNewsWire • Feb 4, 2026

Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates

Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago.

Zacks Investment Research • Feb 5, 2026

What's in Store for Core Laboratories Stock in Q4 Earnings?

CLB is expected to report higher revenues than the year-ago period's level. However, it is expected to have faced increased costs and expenses.

Zacks Investment Research • Jan 29, 2026

HAL vs. CLB: Which Stock Is the Better Value Option?

Investors interested in Oil and Gas - Field Services stocks are likely familiar with Halliburton (HAL) and Core Laboratories (CLB). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Jan 27, 2026

Core Laboratories Stock's Stability Makes It a Wise Hold for Now

CLB shows consistent growth, a strong market position and proprietary tech, but faces challenges like cost pressure, international risks and high valuation concerns.

Zacks Investment Research • Jan 6, 2026

CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026.

PRNewsWire • Jan 5, 2026

Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now

CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties.

Zacks Investment Research • Dec 3, 2025